Epilepsy deaths: level of risk in medication brand switch unclear, study says

17 January 2020 - Five deaths in people with epilepsy following a brand switch may be part of an under-represented level ...

Read more →

PHARMAC epilepsy drug process questions

10 January 2020 - There are many unanswered questions about PHARMAC's decision to fund only one brand of the epilepsy ...

Read more →

Abuses of FDA regulatory procedures - the case of Suboxone

8 January 2020 - The manufacturer of brand-name buprenorphine products exploited various FDA regulatory procedures to impede market entry of generic ...

Read more →

'The public deserves to know why' - National intensifies calls for inquiry into PHARMAC after fifth death linked to epilepsy drug Logem

2 January 2020 - The National Party has intensified its call for a ministerial inquiry into PHARMAC's decision to switch ...

Read more →

FDA’s deadline problem?

3 January 2020 - Rush to meet end-of-year drug-approval deadlines leads to more adverse effects, new study shows. ...

Read more →

PHARMAC brand switch: man driving through Waterview Tunnel blacked out

18 December 2019 - An Auckland man had a seizure and blacked out as he drove through Auckland's Waterview Tunnel after ...

Read more →

Calls for answers about PHARMAC delay after epilepsy deaths

17 December 2019 - The Opposition is calling for answers from the Government about why it took two weeks for ...

Read more →

PHARMAC knew of epilepsy deaths for weeks but stayed silent

17 December 2019 - PHARMAC knew for more than two weeks that three deaths had been linked to its epilepsy ...

Read more →

Six-year review shows success of the EU signal management system in improving safe use of medicines

11 December 2019 - In the first six years since the implementation of the 2012 EU pharmacovigilance legislation, the EU ...

Read more →

PHARMAC says it welcomes a joint inquiry into four deaths - which have all been linked to the anti-epileptic drug, Logem

6 December 2019 - Chief Coroner Judge Deborah Marshall made the announcement today. ...

Read more →

Epilepsy patients angry at being told symptoms all in their heads

5 December 2019 - PHARMAC funded research into whether people with epilepsy were imagining side effects from a medicine brand change ...

Read more →

PHARMAC funded video downplays side effects of drug linked to four unexplained deaths, epilepsy patients say

5 December 2019 - Epilepsy patients are upset about a PHARMAC funded video which they say downplays the side effects of ...

Read more →

Epilepsy sufferer says victims of PHARMAC drug switch should be compensated

19 November 2019 - An epilepsy sufferer who urged others to boycott the Government's change in anti-epileptic drug medication is ...

Read more →

PHARMAC backs down on epilepsy drug brand switch

15 November 2019 - PHARMAC has backed down on a controversial drug brand switch affecting patients with epilepsy and mental ...

Read more →

PHARMAC to widen access to the exceptional circumstances process for lamotrigine

15 November 2019 - Patients taking lamotrigine who have concerns about the change can talk with their doctor about remaining ...

Read more →